经口内镜下肌切开术用于既往有无Heller肌切开术的患者:美国单中心大型队列的长期结局比较(附视频)
本研究基于2009年10月至2016年10月连续318例经口内镜下肌切开术(POEM)的前瞻性数据库,比较46例既往接受过Heller肌切开术(HM)的患者与其余272例患者的疗效与安全性。结果显示两组在手术参数及随访结局(临床成功率、Eckardt评分、食管下括约肌压力、GERD评分、食管炎及pH检测)上无显著差异;HM-POEM组围手术期无临床显著不良事件,中位随访28个月时总体临床成功率为95.7%。作者认为POEM作为HM失败患者的补救治疗可行、安全且高效。
要点
- 既往HM患者与无HM患者POEM术后临床成功率、Eckardt评分、LES压力等随访结局无显著差异。
- 46例HM-POEM患者围手术期无临床显著不良事件,中位随访28个月临床成功率为95.7%。
- 作者认为在POEM经验丰富的中心,POEM应作为HM失败患者的首选治疗。
核心结论
- POEM作为Heller肌切开术失败后贲门失弛缓症患者的补救治疗可行、安全且高效。
- 作者认为在POEM经验丰富的中心,POEM应作为此类困难病例的首选治疗。
研究设计与样本
- 前瞻性数据库中选择距POEM至少3个月的患者,纳入2009年10月至2016年10月连续318例POEM。
- 比较46例既往有Heller肌切开术(HM)患者与其余272例患者的POEM疗效与安全性。
主要发现
- 既往HM患者病史更长、疾病更进展、I型贲门失弛缓症更多而II型更少、POEM前Eckardt评分更低、POEM前食管下括约肌压力更低(均P < .01)。
- 两组手术参数及随访结果(临床成功率、Eckardt评分、LES压力、GERD评分、食管炎及pH检测)无显著差异。
- 46例HM-POEM患者围手术期无临床显著不良事件。
- HM-POEM患者总体临床成功率(Eckardt评分≤3且无需其他治疗)在中位随访28个月时为95.7%。
关键数值与推荐
- 临床成功定义为Eckardt评分≤3且无需其他治疗。
- HM-POEM患者中位随访28个月时总体临床成功率为95.7%。
临床怎么用
- 作者认为POEM作为Heller肌切开术失败后贲门失弛缓症的补救治疗可行、安全且高效。
- 作者认为在POEM经验丰富的中心,POEM应作为此类困难病例的首选治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Heller's myotomy (HM) is one of the most effective treatments for esophageal achalasia. However, failures do exist, and the success rate tends to decrease with time. The efficacy of rescue treatments for patients with failed HM is limited. A few small-scale studies have reported outcomes of per-oral endoscopic myotomy (POEM) in these patients. We conducted this study to systematically assess feasibility, safety, and efficacy of POEM on patients who have had HM. METHODS: Patients at least 3 months out from POEM were selected from our prospective database: 318 consecutive POEMs performed from October 2009 to October 2016. The efficacy and safety of POEM were compared between the 46 patients with prior HM and the remaining 272 patients. RESULTS: Patients with prior HM had longer disease history, more advanced disease, more type I and less type II achalasia, lower before-POEM Eckardt scores, and lower before-POEM lower esophageal sphincter (LES) pressure (all P < .01). Procedure parameters and follow-up results (clinical success rate, Eckardt score, LES pressure, GERD score, esophagitis, and pH testing) showed no significant difference between the 2 groups. For the 46 HM-POEM patients, no clinically significant perioperative adverse events occurred. Their overall clinical success rate (Eckardt score ≤3 and no other treatment needed) was 95.7% at a median follow-up of 28 months. CONCLUSION: POEM as a rescue treatment for patients with achalasia who failed HM is feasible, safe, and highly effective. It should be the treatment of choice in managing these challenging cases at centers with a high level of experience with POEM.
引用
- Zhang X, Modayil RJ, Friedel D, et al. Per-oral endoscopic myotomy in patients with or without prior Heller's myotomy: comparing long-term outcomes in a large U.S. single-center cohort (with videos). Gastrointest Endosc. 2017. PMID: 29122601. doi:10.1016/j.gie.2017.10.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。